John Zhu is the founder of Duality Biologics. Duality Biologics has raised $120M in total funding. Latest round: Series B. Based in Shanghai, China.
John Zhu is the founder and Chief Executive Officer of Duality Biologics, a clinical-stage biotechnology company established in 2020. The company focuses on developing next-generation antibody-drug conjugates (ADCs) and bispecifics for oncology and autoimmune diseases. Recognized as a "rockstar founder," Zhu secured over $120 million in funding for the company, which is now publicly listed on the Hong Kong Stock Exchange.
Full founder directory · Investor directory · Company funding database · Fundraising library